Phase II Study of Aflibercept (VEGF-Trap) in Patients With Recurrent or Metastatic Urothelial Cancer, a California Cancer Consortium Trial
Urology - United States
doi 10.1016/j.urology.2010.04.025
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 1, 2010
Authors
Publisher
Elsevier BV